Beacon Therapeutics Holdings Limited

Beacon Therapeutics is an ophthalmic gene therapy company focused on saving and restoring vision for patients with blinding retinal diseases. Their lead asset, AGTC-501, is in a registrational clinical trial for X-Linked Retinitis Pigmentosa, and they also have preclinical programs targeting dry age-related macular degeneration and cone-rod dystrophy.

Buy Funded Startups lists

Funding Round: Series B

Funding Amount: $170M

Date: 03-Jul-2024

Investors: Forbion, Syncona Limited, Oxford Science Enterprises, TCGX, Advent Life Sciences

Markets: Ophthalmology, Gene Therapy, Biotechnology Research, Health Care, Therapeutics

HQ: Alachua, Florida, United States

Founded: 2023

Website: https://www.beacontx.com/

LinkedIn: https://www.linkedin.com/company/beacon-therapeutics

Twitter: https://twitter.com/beacontx_

Instagram: